The American Psychological Foundation is inviting applications for its Walter Katkovsky Research Grants.
Through the program, grants of up to $20,000 will support research on the benefits of combining psychotherapy with a psychoactive substance (either over-the-counter or some other legal substance or prescription medication), where the substance is an adjunct to the psychotherapy and not the primary intervention. Although determining the effectiveness of the psychoactive substance (whether it consists of a prescribed medication or other psychoactive substance) and its dosage may be intrinsic to the research, the hypotheses to be tested should not be related to the psychoactive substance per se but rather on conditions that may be associated with decisions to introduce or discontinue the substance in the treatment plan and with the outcomes of combining these treatments.
Examples include but are not limited to the following: individual differences in patient variables that may favor or contraindicate combining psychotherapy and a psychoactive substance; in-therapy variations in goals, structure, methods, theoretical orientation, therapist/patient interactions, and expected frequency and duration of meetings as they affect the appropriateness of combined treatments; and research to establish recommendations on process variables on how best to introduce alternatives that may include changing or discontinuing a medication or another psychoactive substance.
To be eligible, applicants must be a psychologist with up to twelve years of postdoctoral experience affiliated with a nonprofit charitable, educational, or scientific institution or a governmental entity operating exclusively for charitable and educational purposes.
See the American Psychological Foundation website for complete program guidelines, application instructions, and details about past recipients.